REFERENCES
  1. Freeman, J. V., Varosy, P., Price, M. J., Slotwiner, D., Kusumoto, F. M., Rammohan, C and Masoudi, F. A. The NCDR left atrial appendage occlusion registry. Journal of the American College of Cardiology 2020 75(13), 1503-1518.
  2. Kar, S., Doshi, S. K., Sadhu, A., Horton, R., Osorio, J., Ellis, C. and PINNACLE FLX Investigators. Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial. Circulation. 2021 143(18), 1754-1762.
  3. Schmidt B, Betts TR, Sievert H, et al. Incidence of pericardial effusion after left atrial appendage closure: the impact of underlying heart rhythm— data from the EWOLUTION study. J Cardiovasc Electrophysiol 2018;29:973–8.
  4. Reddy VY, Gibson DN, Kar S, et al. Post-FDA approval, initial U.S. clinical experience with Watchman left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2017;69:253–61.
  5. Nandkeolyar S, Parwani P, Contractor T. A Case of Delayed Hemorrhagic Effusive-Constrictive Pericarditis After Left Atrial Appendage Occlusion Device Placement. JACC: ase Reports. 2019;1(1):27-31.